Research projects

Pushing research forward

From bench to bedside

See IDIBELL's portfolio

Innovation & Business Development

Transfering knowledge to society

The future of health is in our hands.

Support IDIBELL’s research.

Donate
RESEARCH PROJECTS
117
national competitive projects granted in 2024 worth

14.158.408,21 €

16
international competitive projects granted in 2024 worth

3.546.618,37 €

Innovation

& Business development

IDIBELL facilitates and promotes the transfer of the knowledge generated by its researchers through clinical trials, patents, codevelopment agreements or the creation of spin-off companies. Since 2020, priorities included adding more value to the portfolio and designing new strategies for internationalization to become more competitive worldwide.

Learn More

12 innovation competitive projects

(worth 2.101.884,81 €)

200 new clinical trials

4 internal promoter
196  external promoter

153 active patents

belonging to 31 families (and 3 software registrations)

20 licences &
5 active spin-offs

XENOPAT

REMAb Tx

ADmit Tx

Aptadel Therapeutics

AtG Therapeutics

253 projects in portfolio

From which 49 are prioritized projects including m-health & medical devices, technologies, drug discovery & personalised medicine

61 R+D contracts

43 national
18 international